ABOUT EVENT
Hanson Wade Group have taken the decision to cancel this meeting.
Please accept our apologies for any inconvenience or disappointment caused.
Welcome to the TGF-B Targeted Drug
Development Summit
The TGF-B Targeted Drug Development Summit is the go-to event for biotech and pharma companies wanting to expand their knowledge, showcase their research, and network with other industry leaders in the TGF-B space.
Key TGF-B Highlights
Deep-dive into the different TGF-B combination strategies turning tumors from ‘cold’ to ‘hot’ and activating an immune response to achieve positive patient outcomes with Genentech, iOnctura, and Y-Trap
Discover clinical successes in immuno-oncology with better predictive biomarkers, reduced toxicity & increased specificity for TGF-B directed therapies with EpicentRx, Synthis, and MAX BioPharma
Extend the reach of TGF-B targeted therapeutics into the realms of fibrosis, autoimmune diseases and beyond to develop clinically effective medicine for patients faster with case studies from Pfizer and Cue BioPharma.
Spotlight the innovative strategies being employed in TGF-B targeted therapies, including oncolytic viruses, ADCs & nanoparticles to directly target tumors & achieve clinical efficacy with KaliVir Immunotherapeutics & General Nanotherapeutics
Unlock the various pathways of pleotropic TGF-B for a deeper mechanistic understanding to develop more effective and targeted therapies with insights from University of Alabama
Hear what TGF-B Leaders of the Field Have to Say:
